
Tedros Adhanom Ghebreyesus, WHO Director-General (Salvatore Di Nolfi/Keystone via AP)
Global license program to receive Covid-19 support from the NIH
A WHO program will see some support from the Biden administration in the fight against Covid-19.
At the second Global Covid-19 Summit, the administration, through the NIH, has decided to officially license 11 Covid-19 research tools and early-stage vaccine and diagnostic candidates. This will be done through the Medicines Patent Pool (MPP), a UN-backed program, through WHO’s Technology Access Pool (C-TAP).
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters